| 产品描述: | L-Ornithine L-aspartate 由鸟氨酸和天冬氨酸组成。它能够减少血氨浓度,并消除与肝硬化相关的肝性脑病的症状。 |
| 体内研究: |
L-Ornithine L-aspartate (300 mg/kg/h,静脉输注) 可预防门系统性脑病 (PSE) 大鼠的氨诱发昏迷。 L-Ornithine L-aspartate (2 g/kg,口服 10 天) 可保护硫代乙酰胺 诱导的大鼠肝损伤。 |
| 参考文献: |
1. Sikorska H, et al. [Physiological functions of L-ornithine and L-aspartate in the body and the efficacy of administration of L-ornithine-L-aspartate in conditions of relative deficiency]. Pol Merkur Lekarski. 2010 Jun;28(168):490-5. 2. Rose C, et al. L-ornithine-L-aspartate in experimental portal-systemic encephalopathy: therapeutic efficacy and mechanism of action. Metab Brain Dis. 1998 Jun;13(2):147-57. 3. Najmi AK, et al. Effect of l-ornithine l-aspartate against thioacetamide-induced hepatic damage in rats. Indian J Pharmacol. 2010 Dec;42(6):384-7. 4. Sisalli MJ, et al. L-Ornithine L-Aspartate Restores Mitochondrial Function and Modulates Intracellular Calcium Homeostasis in Parkinson's Disease Models. Cells. 2022 Sep 17;11(18):2909. |
| 溶解性: |
Souble in H2O |
| 保存条件: |
-80℃(运输条件:冰袋低温运输) |
| 配置溶液浓度参考: |
|
1mg |
5mg |
10mg |
| 1 mM |
3.77 ml |
18.849 ml |
37.699 ml |
| 5 mM |
0.754 ml |
3.77 ml |
7.54 ml |
| 10 mM |
0.377 ml |
1.885 ml |
3.77 ml |
| 50 mM |
0.075 ml |
0.377 ml |
0.754 ml |
|
| 注意: |
部分产品我司仅能提供部分信息,我司不保证所提供信息的权威性,仅供客户参考交流研究之用。 |